切除不能な転移性右側結腸がん、第一選択の併用化学療法を開始の臨床試験
合計3件
-
Yonsei University募集切除不能な転移性右側結腸がん、第一選択の併用化学療法を開始 | 切除不能な転移性右側結腸がん、ステージ IV大韓民国
-
Institut Claudius Regaud完了
-
Fachklinik Hornheide an der Universität Münsterわからない
このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。
スポンサーと協力者
- Kingston Public Hospital
- Magentiq Eye LTD
- Delft Technical University
- German Breast Group
- Hisar Intercontinental Hospital
- Royal Dutch Society for Physiotherapy
- Algiax Pharmaceuticals GmbH
- Prof. Dr. Robbert-Jan Verkes, Radboud University Medical Centre Department of Psychiatry
- Hemptress
- Universitätsklinikum Ulm, Klinik für Anästhesiologie und Intensivmedizin, Albert-Einstein-Allee 23, 89081 Ulm
- Organisms in charge of local cancer screening programs - France
- B. Braun Korea Co., Ltd.
- Hygenic Corporation
- Screenpoint Medical BV
- Lung Clinic Heckeshorn
- Bridgeway Recovery
- Kaiser Foundation Research Institute
- Intech Biopharm Ltd.
- Professor Stewart Walsh
- LEO Foundation
- 全リストを表示
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Brazil
- Contract Research Organizations in Egypt
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Estonia
- Contract Research Organizations in Germany
- Contract Research Organizations in Iran
- Contract Research Organizations in Japan
- Contract Research Organizations in Jordan
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Vietnam
- CRO list by country